国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產品名稱 貨號 規格
Recombinant Schizosaccharomyces pombe Putative NADPH dehydrogenase C5H10.10 (SPAC5H10.10) CSB-YP600646SXV
CSB-EP600646SXV
CSB-BP600646SXV
CSB-MP600646SXV
CSB-EP600646SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C5H10.12c (SPAC5H10.12c) CSB-YP600647SXV
CSB-EP600647SXV
CSB-BP600647SXV
CSB-MP600647SXV
CSB-EP600647SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Dual specificity protein kinase pom1 (pom1), partial CSB-YP600648SXV
CSB-EP600648SXV
CSB-BP600648SXV
CSB-MP600648SXV
CSB-EP600648SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Mediator of RNA polymerase II transcription subunit 1 (med1) CSB-YP600649SXV
CSB-EP600649SXV
CSB-BP600649SXV
CSB-MP600649SXV
CSB-EP600649SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Palmitoyltransferase akr1 (akr1), partial CSB-YP600650SXV1
CSB-EP600650SXV1
CSB-BP600650SXV1
CSB-MP600650SXV1
CSB-EP600650SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C2F7.16c (SPAC2F7.16c), partial CSB-YP600651SXV
CSB-EP600651SXV
CSB-BP600651SXV
CSB-MP600651SXV
CSB-EP600651SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe ATP-dependent RNA helicase dbp10 (dbp10), partial CSB-YP600652SXV
CSB-EP600652SXV
CSB-BP600652SXV
CSB-MP600652SXV
CSB-EP600652SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Sister chromatid cohesion protein mis4 (mis4), partial CSB-YP600653SXV
CSB-EP600653SXV
CSB-BP600653SXV
CSB-MP600653SXV
CSB-EP600653SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Probable ubiquitin carboxyl-terminal hydrolase 8 (ubp8) CSB-YP600654SXV
CSB-EP600654SXV
CSB-BP600654SXV
CSB-MP600654SXV
CSB-EP600654SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Protein ste16 (ste16) CSB-YP600655SXV
CSB-EP600655SXV
CSB-BP600655SXV
CSB-MP600655SXV
CSB-EP600655SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Putative membrane-bound O-acyltransferase C24H6.01c (SPAC24H6.01c, SPAPB21F2.01) CSB-YP600656SXV
CSB-EP600656SXV
CSB-BP600656SXV
CSB-MP600656SXV
CSB-EP600656SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Rho guanine nucleotide exchange factor gef1 (gef1), partial CSB-YP600657SXV
CSB-EP600657SXV
CSB-BP600657SXV
CSB-MP600657SXV
CSB-EP600657SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Meiotically up-regulated gene 62 protein (mug62), partial CSB-YP600658SXV
CSB-EP600658SXV
CSB-BP600658SXV
CSB-MP600658SXV
CSB-EP600658SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C1D4.14 (SPAC1D4.14, SPAC22F3.14c) CSB-YP600659SXV
CSB-EP600659SXV
CSB-BP600659SXV
CSB-MP600659SXV
CSB-EP600659SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Nucleoporin nup45 (nup45) CSB-YP600660SXV
CSB-EP600660SXV
CSB-BP600660SXV
CSB-MP600660SXV
CSB-EP600660SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe PAB-dependent poly (A)-specific ribonuclease subunit pan2 (ubp13), partial CSB-YP600661SXV
CSB-EP600661SXV
CSB-BP600661SXV
CSB-MP600661SXV
CSB-EP600661SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Probable nucleolar pre-ribosomal-associated protein 2 (urb2) CSB-YP600662SXV
CSB-EP600662SXV
CSB-BP600662SXV
CSB-MP600662SXV
CSB-EP600662SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Putative transcription initiation factor TFIID 111 kDa subunit (SPAC2G11.14) CSB-YP600663SXV
CSB-EP600663SXV
CSB-BP600663SXV
CSB-MP600663SXV
CSB-EP600663SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Putative general negative regulator of transcription C16C9.04c (SPAC16C9.04c) CSB-YP600664SXV
CSB-EP600664SXV
CSB-BP600664SXV
CSB-MP600664SXV
CSB-EP600664SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Meiotic recombination protein rec10 (rec10), partial CSB-YP600665SXV
CSB-EP600665SXV
CSB-BP600665SXV
CSB-MP600665SXV
CSB-EP600665SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質形式,可以通過多種方式產生大量蛋白質、修改基因序列和制造有用的商業產品。重組蛋白的技術資源在重組蛋白的開發過程中,除了表達系統之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質量的重組蛋白,后續的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據他們開發重組蛋白的經驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產,在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質合成機制來產生由該基因編碼的蛋白質。表達載體可使外源基因在宿主細胞中高效表達,經過多年的發展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質?

根據重組蛋白的不同應用,對其生物活性有不同的要求。但是我們如何確保蛋白質的產生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質有任何疑問,涉及到蛋白質的價格、交貨、質量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>